We congratulate Evan Cantor, MD, JD, on the publication of his first author manuscript, “Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1”, in Childs Nervous System. Nicole Brossier, MD, PhD, hopes this might provide rationale for further investigation into the use of MEK inhibitors in controlling epilepsy in patients with NF1.
Full citation: Cantor E, Meyer A, Morris SM, Weisenberg JLZ, Brossier NM. Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1. Childs Nerv Syst. 2022 Jun 1. doi: 10.1007/s00381-022-05571-y. Epub ahead of print. PMID: 35648241.